U.S. Basic Materials Stock News

Okta’s special call puts AI identity security in focus Okta (OKTA) recently held a special call alongside fresh recognition for its collaboration with Master Concept in Asia, putting a spotlight on how identity security fits into complex cloud and AI environments. For investors watching Okta stock, the award for Master Concept under the Okta Catalyst Award for Strategic Excellence, together with the company’s published analysis of enterprise AI usage, offers a window into where management is...

Earlier this week, Gap announced it had partnered with beauty entrepreneur and influencer Hailey Bieber to launch “The Hailey Jean,” a limited-edition ’90s-inspired relaxed denim capsule featuring Extra Baggy and ’90s Low Rise Loose fits with 1996-themed detailing, available online and in select stores. The collaboration highlights Gap’s effort to connect heritage denim with culture-led marketing, using Bieber’s influence to reach younger shoppers and reinforce its focus on relaxed...

Urban Outfitters recently expanded its beauty assortment by bringing emerging skincare brand Yes Day Beauty to 60 U.S. stores and online, marking Yes Day’s first physical retail presence in the country with products like Float Foam™ Cleanser (US$24) and Whip Dream Moisturizer (US$32). This exclusive brick-and-mortar launch highlights Urban Outfitters’ push into higher-margin, branded beauty offerings that can deepen customer engagement beyond its core apparel business. We’ll now look at how...

Chemed (CHE) has drawn investor attention after recent trading, with the stock last closing at US$510.03. That move comes alongside fresh interest in how its hospice and plumbing businesses support the current valuation. See our latest analysis for Chemed. Recent trading fits into a broader upswing for Chemed, with a 30 day share price return of 16.97% and a 90 day share price return of 32.61%. This contrasts with a 3 year total shareholder return that is down 8.16%, suggesting momentum has...

FMC (FMC) stock is in focus after the company submitted its first regulatory dossier for the new herbicide rimisoxafen to the U.S. Environmental Protection Agency, marking the compound’s initial global filing. See our latest analysis for FMC. Despite the positive headlines around rimisoxafen, FMC’s recent trading tells a different story, with the share price down 34.7% over 90 days and the 1 year total shareholder return declining 72.4%. This points to fading momentum as investors reassess...

Target Hospitality stock has delivered a very large 359.6% total return over the past five years, yet the current valuation checks lean expensive, with a low overall value score and market multiples that screen as overvalued. A 359.6% five year return means long term shareholders have already seen substantial gains, so fresh buyers are coming in after a strong run. Future contract wins and utilization levels can support earnings and cash flow, but any disappointment in occupancy or pricing...

Tradeweb Markets (TW) is back in focus after reporting June and second quarter 2026 operating metrics that show sharply higher trading activity, alongside a move to supply institutional bond pricing into the Pyth Network’s digital and onchain ecosystem. See our latest analysis for Tradeweb Markets. Despite the strong June and second quarter trading metrics, Tradeweb Markets’ recent share price return has been weak, with the stock down over the past quarter and year to date. However, the three...

Trump Media & Technology Group’s plan to charge up to US$100,000 per month for high speed API access to President Trump’s Truth Social posts is turning market information itself into a premium product. When a single message can jolt the S&P 500, oil prices, or individual stocks, the gap between traders who see that data first and everyone else can matter. This article looks at three stocks exposed to this new pay to see model, with one potentially positioned on the right side of the trend and...

Sticky inflation, a firm jobs market, and a Federal Reserve that signals it may keep policy tight or even tighten further all put a spotlight on companies tied to AI infrastructure and data centers. Capital spending linked to AI could both support earnings potential and add fresh inflation pressure, so stock selection matters. This article looks at how those macro forces intersect with AI related demand, and highlights three stocks with positive exposure from our AI Infrastructure and Data...

AECOM (ACM) is back in the spotlight after securing several high profile public infrastructure roles, including Queensland’s The Wave rail project, Canada’s Alexandra Bridge replacement, and Thames Water’s Oxford Sewage Treatment Works upgrade. See our latest analysis for AECOM. Despite landing these large public infrastructure roles, AECOM’s share price has fallen 21.15% over the past 90 days and is down 29.16% year to date, while the 1 year total shareholder return has declined 38.93%. This...

Analyst attention puts Welltower in focus Fresh analyst commentary has put Welltower (WELL) back on investors’ radar, with Wells Fargo and Bank of America Securities reiterating positive views, while Barclays has begun coverage with a more neutral stance. This combination of supportive and neutral ratings gives investors a timely prompt to reassess how Welltower’s current share price and business profile align with their own expectations and risk tolerance. See our latest analysis for...

Salesforce stock has dropped 34.4% over the past year even as broader valuation checks still suggest the shares lean cheap. This puts the current price in the middle of a tug-of-war between weak recent returns and a relatively supportive valuation profile. Over the last 12 months, Salesforce is down 34.4%, a drawdown that has reset expectations and pushed investors to reassess what a reasonable entry price looks like. On one side, large AI related investments and mixed sentiment around the...

Eton Pharmaceuticals has turned heads with a very large 3 year return and a fresh 52 week run, yet its current checks paint a picture of a stock that screens as expensive rather than a clear bargain. Over the past 3 years, Eton Pharmaceuticals has delivered a very large total return of about 13x. This puts extra focus on whether recent optimism has already been reflected in the share price. Recent momentum around a new FDA approved drug agreement can support expectations for future revenue...

Snap-on (SNA) is in focus after recent trading left the stock at a last close of $410.99, prompting investors to reassess its valuation signals, including an intrinsic discount figure and current return profile. See our latest analysis for Snap-on. Despite a small 0.96% decline in the latest trading session, Snap-on’s recent 7.80% 30 day share price return and 17.11% year to date share price return sit alongside a 25.42% 1 year total shareholder return. This suggests that momentum has been...

Digital Turbine stock has rebounded strongly in the short term, yet the valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while market multiples suggest the shares may be on the cheap side. Over the past 5 years the share price has declined about 86.9%, which leaves recent gains set against a much weaker longer term record for investors who held through the period. Expectations for Digital Turbine to sustain and convert its revenue...

In recent weeks, Honeywell International completed its acquisition of Johnson Matthey’s Catalyst Technologies business while reaffirming full-year 2026 sales guidance of US$19.90 billion to US$20.20 billion and updated earnings guidance that separates spin-off effects from ongoing performance. By expanding its catalyst and process technologies portfolio, advancing community-scale solar projects, and earning top marks for family-friendly workplaces, Honeywell is reinforcing an...

Alnylam Pharmaceuticals (ALNY) is drawing attention after advancing its Alzheimer’s disease pipeline by initiating a Phase 2 trial of mivelsiran in Down syndrome-associated Alzheimer’s and completing enrollment in a related cerebral amyloid angiopathy study. See our latest analysis for Alnylam Pharmaceuticals. Despite the Alzheimer’s updates, Alnylam Pharmaceuticals’ share price has come under pressure, with the stock down 10.47% over the past week and 33.16% on a year to date share price...

Lyft, Inc. and Curb recently expanded their partnership to New York City, allowing eligible Lyft riders to be matched with licensed taxis through Curb Flow directly in the Lyft app, extending an integration already active in Los Angeles and San Francisco. This move gives Lyft access to New York’s extensive taxi fleet without new hardware for drivers, reinforcing its model of adding supply through licensed operators rather than owning vehicles itself. Next, we’ll examine how tapping New...

Cleveland-Cliffs stock is coming off a difficult stretch, with the share price down 57.0% over the past 5 years, yet both the intrinsic value estimate using a Discounted Cash Flow (DCF) approach and conventional market multiples currently point to the shares trading below what the underlying cash flows may justify. The 57.0% share price decline over 5 years leaves existing holders with a steep loss, while raising the question of whether expectations have swung too far to the pessimistic...

CAVA Group stock has given investors a solid 41.1% gain over the past three years, yet the latest valuation checks and recent share price pullback raise questions about whether the current level still makes sense or now leans expensive. Over the past three years, CAVA Group has returned 41.1%. This puts the recent share price weakness into context as a pause after a stronger multi year run. The planned expansion of the restaurant base can support higher revenue expectations over time. The...

WaFd (WAFD) has put up a clean set of Q3 2026 numbers, with total revenue of about US$194.5 million and basic EPS of roughly US$0.85 feeding into trailing 12 month revenue of about US$761.1 million and EPS of around US$3.17. The company has seen revenue move from about US$721.1 million on a trailing basis in Q3 2025 to roughly US$761.1 million by Q3 2026, while trailing EPS shifted from about US$2.62 to US$3.17, setting the backdrop for investors weighing slower top line growth against firmer...

nLIGHT’s stock has delivered very strong gains over the past few years, yet the latest valuation checks, including an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples, both point to the shares trading at a premium to those fundamentals. Over the last 3 years, nLIGHT has returned about 376.6%, which puts extra focus on whether recent gains are already pricing in much of its future potential. The recent award of a Pentagon contract with funding...

Merit Medical Systems stock has delivered a modest 15.2% gain over the past five years, and today its valuation signals are split. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while earnings-based multiples suggest the shares trade at a premium. That tension leaves investors weighing a DCF view that screens the stock as undervalued against a market multiple read that looks less forgiving. Over five years, Merit Medical Systems has returned 15.2%, which...

Diamondback Energy stock has delivered a very strong 208.9% return over the past 5 years. With the latest checks pointing to an about-right market multiple and a mixed overall value score, the question is whether the current price still offers an appealing entry point or largely reflects that strength. Over 5 years, Diamondback Energy has returned 208.9%, which puts recent gains in context and raises the bar for any new upside to be supported by fundamentals. Expectations around oil-linked...